Limited Time Offer Gp100110: Arg8-cgsg-muc1(137-156)-tn(144) Special: 90% Discount [Aw9Y8ahn]

GP100110: MUC1 Glycopeptide Fragment

Introducing our premium synthetic glycopeptide fragment, GP100110, derived from the MUC1 protein. This product offers a unique opportunity for researchers to study the tumor-associated carbohydrate antigen (TACA) and its role in cancer biology. With its specific amino acid sequence and conjugation features, GP100110 is a valuable tool for various applications in the field of oncology research.

• Highly Pure: Our MUC1 glycopeptide fragment is synthesized with exceptional purity, ensuring reliable and consistent results in your experiments.
• Specificity: The fragment contains the tumor-associated carbohydrate antigen Tn (GalNAcα-O-Thr) at Thr144, making it ideal for studying the interaction between MUC1 and tumor-specific antigens.

Product Features and Specifications

GP100110 is a 20-amino acid fragment spanning from Gly137 to His156 of the MUC1 protein. It is conjugated at the N-terminus with Arg8, separated from the MUC1 sequence by a Cys-Gly-Ser-Gly linker. The C-terminus is capped with an amide, providing stability and ease of use. This synthetic glycopeptide fragment is designed to mimic the natural structure of MUC1, allowing for accurate research and analysis.

• Conjugation and Linker: The N-terminus of GP100110 is conjugated with Arg8, providing a strong and stable bond. The Cys-Gly-Ser-Gly linker ensures minimal interference with the MUC1 sequence.
• Amide C-terminus: The C-terminus is capped with an amide, preventing degradation and ensuring long-term stability.

Practical Uses and Benefits

Our MUC1 glycopeptide fragment, GP100110, is a versatile tool for a wide range of applications in oncology research. It can be used to study the role of MUC1 in tumor development, its interaction with the immune system, and the potential for therapeutic intervention. The specific features of this product make it an excellent choice for researchers looking to advance their understanding of cancer biology.

• Research Applications: GP100110 is suitable for various research techniques, including ELISA, Western blot, and cell-based assays.
• Therapeutic Insights: By studying the tumor-associated carbohydrate antigen Tn, researchers can gain valuable insights into potential therapeutic targets for cancer treatment.